Tumor initiating cells (TICs) are being extensively studied for their role in tumor etiology, maintenance and resistance to treatment. We describe a novel approach to generate TICs by transduction of human primary breast cell preparations with exogenous expression of the OCT4 transcription factor. The OCT4 transduced breast colonies (OTBCs) underwent an immortalization process, as reflected by loss of p16 and enhanced telomerase expression. OTBCs exhibited cancer stem cell antigens, such as CD44high/CD24low/‐. These cells generated subcutaneous tumors in nude mice with colonization capabilities with 1–50 cells, thereby exhibiting TIC properties. Histological analysis of these tumors revealed poorly differentiated breast carcinomas. RNAi‐mediated knock‐down of OCT4 and downstream embryonic targets of OCT4 resulted in suppression of the self‐renewal ability. OCT4 over‐expression in these clones was molecularly associated with Epithelial‐to‐Mesenchymal Transition (EMT) gene signatures and strongly correlated with the claudin‐low intrinsic subtype of breast cancer. Our experimental approach provides a novel model system to dissect genes that could be used to effectively target breast cancer self‐renewal and tumor initiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.